Christoph Scheiermann

20PUBLICATIONS
117CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cellular nervous systemRespiratory diseasesTumour immunologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Oct 05, 2026
A reciprocally masked anti-CD47/IL-2 fusion protein promotes antitumor immunity and limits systemic toxicity.

|Jul 08, 2026
Circadian screening of neutrophils identifies therapeutic targets in multiple sclerosis.

|Mar 19, 2026
Proteasome-guided haem signalling axis contributes to T cell exhaustion.

Yingxi Xu, Yangtao Shangguan, Yu-Ming Chuang

|Feb 21, 2026
Mast-cell derived nerve growth factor drives ILC2 pro-tumoral functions in bladder cancer.

Maryline Falquet, Hajar El Ahanidi, Alejandra Gomez-Cadena

|Feb 02, 2026
Time-of-day immunochemotherapy in non-small cell lung cancer: a randomized phase 3 trial.

Zhe Huang, Liang Zeng, Zhaohui Ruan

|Mar 21, 2025
STIM1/2 maintain signaling competence at ER-PM contact sites during neutrophil spreading.

Camille Rabesahala de Meritens, Amado Carreras-Sureda, Nicolas Rosa

Pageof 4

Frequent Collaborators

8 joint publications

Robert Pick

7 joint publications

Chen Wang

5 joint publications

Coline Barnoud

4 joint publications

Louise Madeleine Ince